Lanzostad

Lansoprazole, the active ingredient in Lanzostad, is a proton pump inhibitor presented as an oral dosage form for oral use. It is used to reduce gastric acid production in adults with acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease. GNH USA supplies Lanzostad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing by reducing gastric acidity. - Helicobacter pylori eradication therapy: enhances the effectiveness of antibiotic regimens by suppressing acid. - Erosive oesophagitis: aids mucosal recovery by maintaining a higher gastric pH.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, often transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Before prescribing Lanzostad, clinicians should consider several safety aspects. - Assess renal function: adjust use in severe impairment. - Monitor for infections: prolonged therapy may increase risk of gastrointestinal infections. - Review concomitant medications: avoid drugs that require acidic pH for absorption. - Use cautiously in elderly patients: higher incidence of fractures and electrolyte disturbances. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Ketoconazole: markedly reduced absorption when taken together. - Atazanavir: decreased antiviral effectiveness due to higher gastric pH. - Clopidogrel: reduced conversion to its active metabolite, diminishing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Digoxin: elevated serum levels may occur, necessitating dose adjustment.